Patent Assignment
Reel/Frame 047697/0210
Merger
Recorded: 2018-11-30
Pages: 3
Assignor
NEUROVANCE, INC.
Executed: 2017-11-30
Assignee
OTSUKA AMERICA PHARMACEUTICAL, INC.
2440 RESEARCH BLVD., ROCKVILLE, MARYLAND, 20850
Covered Property
(1)
Sustained Release Pharmaceutical Compostions Comprising (1R,5S)-1-(NAPHTHALEN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE
Application:
15/102,949 →
Publication:
US 2016/0303077